Hadassah

A Mysterious Case Sends a Family Searching for Cures, Finding Hadassah

Monday, Oct 6 2014

Nine-year-old Tasnin had spent most of her life going from doctor to doctor, as one cold and respiratory infection followed the next. For a long time, doctors were unable to diagnose the cause until Hadassah’s genetic experts identified the culprit and cured her--a breakthrough that will be highlighted in one of the world’s top hematology journals in the coming months.

Tasnin, who is the middle daughter of five sisters, was often so sick she had to be hospitalized. But doctors believed it was “just a virus,” and she would outgrow this pattern of continually contracting these respiratory illnesses.

Tasnin’s parents, particularly her dad, Muhammed, who is a chef in a restaurant in Jaffa, wouldn’t accept such a fate for their daughter. Muhammed sought help throughout the Palestinian Authority, contacted some Israeli doctors and even consulted with German physicians. And then Tasnin was referred to the Hadassah Medical Organization.

“When I first met Tasnin, she was suffering from a serious form of pneumonia”, relates Dr. Polina Stepensky, a hemato-oncologist who heads Hadassah’s Pediatric Bone Marrow Transplantation Unit. “The biopsy showed that she had a serious problem in her immune system.”

After consulting with Prof. Orly Elpeleg, head of Hadassah’s Genetic and Metabolic Diseases Unit, Dr. Stepensky ordered Whole Exome Sequencing (WES), a futuristic technology which searches through a person’s genes and finds variations in the “coding region” called exons.

While typically this is a very complex process, in this case it was somewhat simpler because the mother and father are cousins and consequently have many genes in common. As a result, it is easier to spot irregularities, which often means that a potentially harmful recessive gene that appears in both parents becomes dominant in their children.

When Hadassah’s genetic team discovered the mutation and checked to see if there were any other cases reported worldwide, they found four: in Germany, Holland, and Lebanon. As a result of this mutation, called IL 21 receptor deficiency, all these patients had passed away. Fortunately, this was not to be Tasnin’s fate since, as Dr. Stepensky explains, “We are the only facility worldwide that uses the WES as a clinical tool, not just as a research tool. On the basis of what we learned, we ordered a bone marrow transplantation, partly using a process developed here at Hadassah. We used the information from the WES to fine-tune the treatment.”

Now Tasnin is healthy and back in school. “We’re delighted,” said Dr. Stepensky. “Not only can we diagnose this gene, but we have a cure for the disease.”

Tasnin’s dad adds: “She’s excelling in school and drawing. But best of all, she's a healthy little girl with a future. I am so grateful. I can’t thank you enough! Blessings to all those who have made this possible.”

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More